1-(tert-butoxycarbonyl)cyclopent-3-ene-1-carboxylic acid

Catalog No.: 
ACYTXH203
CAS No.: 
635318-61-5
Molecular Formula: 
C11H16O4
Molecular Weight: 
212.1
1-(tert-butoxycarbonyl)cyclopent-3-ene-1-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg95%$52.00InquiryInquiry
50mg95%$91.00InquiryInquiry
100mg95%$154.00In stockInquiry
250mg95%$254.00In stockInquiry
1g95%$538.00In stockInquiry
5g95%$2125.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(tert-butoxycarbonyl)cyclopent-3-ene-1-carboxylic acid
IUPAC Name1-(tert-butoxycarbonyl)cyclopent-3-ene-1-carboxylic acid
MDL No.MFCD24483723
Molecular FormulaC11H16O4
Molecular Weight212.1
SMILESO=C(C1(CC=CC1)C(OC(C)(C)C)=O)O
InChI KeyRZAVTKUGXSBXKP-UHFFFAOYSA-N
Synonym1-(tert-butoxycarbonyl)cyclopent-3-ene-1-carboxylicacid;3-Cyclopentene-1,1-dicarboxylic acid, 1-(1,1-dimethylethyl) ester;1-(tert-Butoxycarbonyl)cyclopent-3-ene-1-carboxylic acid - [B72321]
CAS No.635318-61-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACYTXH203 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYTXH203 route product structure diagram
    ACYTXH203635318-61-5In Stock
Inquiry

2. ACYTXH203 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYTXH203 route product structure diagram
    ACYTXH203635318-61-5In Stock
Inquiry

3. ACYTXH203 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYTXH203 route product structure diagram
    ACYTXH203635318-61-5In Stock
Inquiry

Comments (0)